Nanjing Vazyme Biotech Co., Ltd. logo

Nanjing Vazyme Biotech Co., Ltd. (688105)

Market Open
10 Aug, 06:57
SSE SSE
¥
23. 08
-0.14
-0.6029%
¥
9.04B Market Cap
- P/E Ratio
0.4% Div Yield
28.78M Volume
- Eps
¥ 23.22
Previous Close
Add Transaction
Day Range
22.27 24.88
Year Range
12.89 24.88
Want to track 688105 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688105 trading today lower at ¥23.08, a decrease of -0.6029% from yesterday's close, completing a monthly increase of 34.186% or ¥5.88. Over the past 12 months, 688105 stock gained 14.7117%.
688105 pays dividends to its shareholders, with the most recent payment made on Jun 03, 2026. The next estimated payment will be in In 9 months on Jun 03, 2027 for a total of ¥0.65.
The last earnings report, released on Apr 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Nanjing Vazyme Biotech Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jun 03, 2026.
The company's stock is traded on one exchange.

688105 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.52
-0.3141%
Shinva Medical Instrument Co., Ltd.
¥ 12.96
+0.9346%
Inventisbio Co., Ltd.
¥ 21.29
+4.2095%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 20.18
+1.1529%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.33
-1.6746%

Nanjing Vazyme Biotech Co., Ltd. (688105) FAQ

What is the stock price today?

The current price is ¥23.08.

On which exchange is it traded?

Nanjing Vazyme Biotech Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688105.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.4%.

What is its market cap?

As of today, the market cap is 9.04B.

Has Nanjing Vazyme Biotech Co., Ltd. ever had a stock split?

Nanjing Vazyme Biotech Co., Ltd. had 1 splits and the recent split was on Jun 03, 2026.

Nanjing Vazyme Biotech Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Lin Cao CEO
SSE Exchange
CNE100004ZK3 ISIN
CN Country
2,700 Employees
3 Jun 2026 Last Dividend
3 Jun 2026 Last Split
- IPO Date

Overview

Nanjing Vazyme Biotech Co., Ltd is a company specialized in providing advanced technology solutions for the fields of life science, biomedicine, and in vitro diagnostics. Since its inception in 2012, Vazyme Biotech has been committed to innovation and excellence in the development of high-quality reagents and products for molecular biology research, next-generation sequencing (NGS), molecular diagnostics, and bio-medicine. Based in Nanjing, China, the company leverages its expertise in enzyme engineering and bio-manufacturing to support researchers and professionals worldwide, facilitating breakthroughs in scientific research and healthcare.

Products and Services

  • Nucleic Acid Extraction: Offers a comprehensive range of reagents designed for efficient and reliable extraction of DNA and RNA from various sample types.
  • PCR and Cloning/Mutagenesis: Supplies reagents for polymerase chain reaction (PCR) applications, including high-fidelity enzymes and cloning kits for gene modification and expression studies.
  • Nucleic Acid Electrophoresis: Provides solutions for the separation and analysis of DNA and RNA fragments, enabling precise genetic analysis and molecular biology research.
  • Reverse Transcription and Real-Time PCR (qPCR): Offers kits and reagents for converting RNA into cDNA and for the quantification of gene expression through qPCR, critical in gene expression studies and diagnostics.
  • Genome Editing: Supplies tools for cutting-edge genome editing techniques, facilitating gene knockout, knock-in, and mutation studies in various organisms.
  • Cell Biology/Protein Research: Provides a range of products for the analysis and manipulation of proteins and cells, supporting studies in proteomics and cell biology.
  • NGS Library Preparation: Offers a wide array of reagents and automated liquid handling solutions for the preparation of libraries for DNA sequencing, RNA sequencing, single-cell analysis, epigenetics studies, and more, catering to the needs of next-generation sequencing applications.
  • Molecular Diagnosis: Delivers reagents for molecular diagnostic applications, including isothermal amplification, one-step series for simplified workflows, and specific detection kits for pathogens in animals, enhancing capabilities in disease diagnosis and monitoring.
  • Bio-medicine: Supports the biomedicine sector with products for vaccine effectiveness evaluations and the manufacturing process, contributing to the development and quality control of vaccines.

Contact Information

Address: Building D2, Nanjing, China, 210033
Phone: 86 25 8577 1179